Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   

30

Number of overlapping holdings

33.7%

% of WDNA's 91 holdings also in HELX

52.6%

% of HELX's 68 holdings also in WDNA

Overlap by Weight
Sector Drift (WDNA minus HELX)
Overlapping Holdings

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in WDNA
Weight
in HELX
Overlap
ELI LILLY & CO 1.9% 4.2% 1.9%
VERTEX PHARMACEUTICALS INC 1.3% 4.8% 1.3%
DANAHER CORP 1.3% 5.4% 1.3%
IONIS PHARMACEUTICALS, INC. 1.2% 2.7% 1.2%
REGENERON PHARMACEUTICALS 1.2% 4.6% 1.2%

Position Highlights (Non-Overlapping Exposures)
WDNA Overweight Relative to HELX
IOVANCE BIOTHERAPEUTICS INC 3.9%
FATE THERAPEUTICS INC 3.1%
TWIST BIOSCIENCE CORP. 2.9%
NOVOZYMES A/S-B SHARES 2.4%
BLUEPRINT MEDICINES CORP. 2.2%
BRIDGEBIO PHARMA, INC. 2.0%
ALCOBRA LTD 1.7%
VERICEL CORPORATION 1.7%
AGIOS PHARMACEUTICALS INC 1.6%
CARIBOU BIOSCIENCES, INC. 1.6%
WDNA Underweight Relative to HELX
MEDPACE HOLDINGS, INC. -8.0%
THERMO FISHER SCIENTIFIC INC -5.1%
DANAHER CORP -4.2%
KRYSTAL BIOTECH, INC. -3.7%
VERTEX PHARMACEUTICALS INC -3.5%
REGENERON PHARMACEUTICALS -3.4%
BRUKER CORP -3.2%
SARTORIUS AG PREF -3.1%
SAMSUNG BIOLOGICS CO., LTD. -2.9%
CHARLES RIVER LABORATORIES -2.6%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY